PharmChem
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of PharmChem generated cash of $638,894, which is less than the previous year. Cash used in financing activities reached the amount of -$2,350,591 last year. Net change in cash is therefore -$1,711,697.
Cash Flow
| 2017 | 1.22M | 0 | -292.63K |
|---|---|---|---|
| 2019 | 1.81M | 0 | -702.31K |
| 2020 | 2.17M | 0 | -459.80K |
| 2021 | 875.30K | 20K | -6.51M |
| 2022 | 1.26M | 0 | -200.28K |
| 2023 | 638.89K | 0 | -2.35M |
PCHM Cash Flow Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 3.28M | 2.21M | 7.83M | 6.12M | 5.01M | 2.92M |
Operating activities | ||||||
Net income | 845.10K | 870.43K | 1.85M | 1.96M | 1.71M | 1.17M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 170 | 170 | 170 | 2.70K | 5.48K | 7.90K |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | -57.86K | 337.20K | -271.00K | -57.47K | -33.21K | -20.03K |
Inventories | -231.09K | -92.83K | 7.17K | -9.86K | 52.97K | 8.71K |
Accounts payable | 13.81K | -42.61K | -440 | -8.55K | 1.08K | 13.89K |
Cash generated by operating activities | 638.89K | 1.26M | 875.30K | 2.17M | 1.81M | 1.22M |
Investing activities | ||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -4 | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 20K | 0 | 0 | 0 |
Financing activities | ||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | -1.01M | 0 | -702.31K | -585.25K | -702.31K | -292.63K |
Repurchases of common stock | -1.33M | -200.28K | -5.81M | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -125.45K | 0 | 0 |
Cash used in financing activities | -2.35M | -200.28K | -6.51M | -459.80K | -702.31K | -292.63K |
Net Change In Cash | -1.71M | 1.06M | -5.61M | 1.71M | 1.11M | 929.67K |
Cash at end of period | 1.57M | 3.28M | 2.21M | 7.83M | 6.12M | 3.85M |